Cardiex (ASX:CDX) has announced that the Therapeutic Goods Administration has approved its CONNEQT Pulse arterial health monitor for use in Australia.
Cardiex receives TGA approval for CONNEQT Pulse arterial health monitor
June 2, 2025 Australian Biotech
Latest Video
New Stories
-
Health department admits review of blood arrangements considering defunding products
June 3, 2025 - - Latest News -
New data uncovers our most painful moments as access to treatment expands
June 2, 2025 - - Latest News -
Australian innovation could revolutionise the early detection of ovarian cancer
June 2, 2025 - - Latest News -
AusBiotech welcomes shadow ministry and encourages bipartisan support for life sciences sector
June 2, 2025 - - Latest News -
Radiopharm Theranostics reports Preclinical Lu177-B7H3-mAb data
June 2, 2025 - - Australian Biotech -
Neurotech announces positive human PK study results for NTI164
June 2, 2025 - - Australian Biotech -
Cardiex receives TGA approval for CONNEQT Pulse arterial health monitor
June 2, 2025 - - Australian Biotech